As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.

SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

Vaxxas has been awarded a tender by the European Health and Digital Executive Agency to help develop next-generation ...

SK Bioscience said Thursday it has secured its first European Union-backed vaccine development project alongside German subsidiary IDT Biologika, marking a key ...

SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

Explore essential statistical strategies for accurate protein quantification and differential expression analysis.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

A Brisbane-based biotechnology company behind a needle-free vaccine patch has warned it could take its technology offshore after securing a multimillion-dollar funding boost from European authorities, ...

The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ ...

Allied Market Research published a report, titled, "Limb Prosthetics Market by Type (Upper Limb Prosthetics and Lower Limb Prosthetics), ...